HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 241 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2022. The put-call ratio across all filers is 1.21 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,169 | -17.8% | 35,685 | -11.7% | 0.06% | -11.3% |
| Q2 2023 | $1,422 | +218.8% | 40,415 | +195.8% | 0.06% | +195.2% |
| Q1 2023 | $446 | -53.4% | 13,665 | -21.4% | 0.02% | -60.4% |
| Q4 2022 | $958 | -99.9% | 17,393 | +15.9% | 0.05% | +32.5% |
| Q3 2022 | $664,000 | -10.9% | 15,003 | -1.8% | 0.04% | -28.6% |
| Q2 2022 | $745,000 | -39.4% | 15,285 | -39.5% | 0.06% | -30.9% |
| Q1 2022 | $1,230,000 | – | 25,281 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |